Cargando…

Natural products as potential cancer therapy enhancers: A preclinical update

Cancer is a multifactorial disease that arises as a consequence of alterations in many physiological processes. Recently, hallmarks of cancer were suggested that include sustaining proliferative signaling, evading growth suppressors, resisting cell death, enabling replicative immortality, inducing a...

Descripción completa

Detalles Bibliográficos
Autores principales: Agbarya, Abed, Ruimi, Nili, Epelbaum, Ron, Ben-Arye, Eran, Mahajna, Jamal
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4607199/
https://www.ncbi.nlm.nih.gov/pubmed/26770737
http://dx.doi.org/10.1177/2050312114546924
_version_ 1782395477584510976
author Agbarya, Abed
Ruimi, Nili
Epelbaum, Ron
Ben-Arye, Eran
Mahajna, Jamal
author_facet Agbarya, Abed
Ruimi, Nili
Epelbaum, Ron
Ben-Arye, Eran
Mahajna, Jamal
author_sort Agbarya, Abed
collection PubMed
description Cancer is a multifactorial disease that arises as a consequence of alterations in many physiological processes. Recently, hallmarks of cancer were suggested that include sustaining proliferative signaling, evading growth suppressors, resisting cell death, enabling replicative immortality, inducing angiogenesis, and activating invasion and metastasis, along with two emerging hallmarks including reprogramming energy metabolism and escaping immune destruction. Treating multifactorial diseases, such as cancer with agents targeting a single target, might provide partial treatment and, in many cases, disappointing cure rates. Epidemiological studies have consistently shown that the regular consumption of fruits and vegetables is strongly associated with a reduced risk of developing chronic diseases, such as cardiovascular diseases and cancer. Since ancient times, plants, herbs, and other natural products have been used as healing agents. Moreover, the majority of the medicinal substances available today have their origin in natural compounds. Traditionally, pharmaceuticals are used to cure diseases, and nutrition and herbs are used to prevent disease and to provide an optimal balance of macro- and micro-nutrients needed for good health. We explored the combination of natural products, dietary nutrition, and cancer chemotherapeutics for improving the efficacy of cancer chemotherapeutics and negating side effects.
format Online
Article
Text
id pubmed-4607199
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-46071992016-01-14 Natural products as potential cancer therapy enhancers: A preclinical update Agbarya, Abed Ruimi, Nili Epelbaum, Ron Ben-Arye, Eran Mahajna, Jamal SAGE Open Med Review Paper Cancer is a multifactorial disease that arises as a consequence of alterations in many physiological processes. Recently, hallmarks of cancer were suggested that include sustaining proliferative signaling, evading growth suppressors, resisting cell death, enabling replicative immortality, inducing angiogenesis, and activating invasion and metastasis, along with two emerging hallmarks including reprogramming energy metabolism and escaping immune destruction. Treating multifactorial diseases, such as cancer with agents targeting a single target, might provide partial treatment and, in many cases, disappointing cure rates. Epidemiological studies have consistently shown that the regular consumption of fruits and vegetables is strongly associated with a reduced risk of developing chronic diseases, such as cardiovascular diseases and cancer. Since ancient times, plants, herbs, and other natural products have been used as healing agents. Moreover, the majority of the medicinal substances available today have their origin in natural compounds. Traditionally, pharmaceuticals are used to cure diseases, and nutrition and herbs are used to prevent disease and to provide an optimal balance of macro- and micro-nutrients needed for good health. We explored the combination of natural products, dietary nutrition, and cancer chemotherapeutics for improving the efficacy of cancer chemotherapeutics and negating side effects. SAGE Publications 2014-09-02 /pmc/articles/PMC4607199/ /pubmed/26770737 http://dx.doi.org/10.1177/2050312114546924 Text en © The Author(s) 2014 http://creativecommons.org/licenses/by-nc/3.0/ This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 3.0 License (http://www.creativecommons.org/licenses/by-nc/3.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access page (http://www.uk.sagepub.com/aboutus/openaccess.htm).
spellingShingle Review Paper
Agbarya, Abed
Ruimi, Nili
Epelbaum, Ron
Ben-Arye, Eran
Mahajna, Jamal
Natural products as potential cancer therapy enhancers: A preclinical update
title Natural products as potential cancer therapy enhancers: A preclinical update
title_full Natural products as potential cancer therapy enhancers: A preclinical update
title_fullStr Natural products as potential cancer therapy enhancers: A preclinical update
title_full_unstemmed Natural products as potential cancer therapy enhancers: A preclinical update
title_short Natural products as potential cancer therapy enhancers: A preclinical update
title_sort natural products as potential cancer therapy enhancers: a preclinical update
topic Review Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4607199/
https://www.ncbi.nlm.nih.gov/pubmed/26770737
http://dx.doi.org/10.1177/2050312114546924
work_keys_str_mv AT agbaryaabed naturalproductsaspotentialcancertherapyenhancersapreclinicalupdate
AT ruiminili naturalproductsaspotentialcancertherapyenhancersapreclinicalupdate
AT epelbaumron naturalproductsaspotentialcancertherapyenhancersapreclinicalupdate
AT benaryeeran naturalproductsaspotentialcancertherapyenhancersapreclinicalupdate
AT mahajnajamal naturalproductsaspotentialcancertherapyenhancersapreclinicalupdate